Concepedia

J.F. Liu

JL

Statistics

Publications

4

Citations

62

H-Index

4

Active since

2018

Affiliations

Massachusetts General Hospital(Current)

Dana-Farber Cancer Institute

Beth Israel Deaconess Medical Center

J.F. Liu is an author at Massachusetts General Hospital specializing in radiation oncology, cancer therapeutics, and obstetrics.

ORCID

Top concepts

Publications per year

2018–2025

4

Publications

4

A phase II trial of combination nivolumab and bevacizumab in recurrent ovarian cancer

J.F. Liu, Christina I. Herold, Wenjie Luo et al. · Annals of Oncology · 2018 · 22 citations · Full text

Lipoic acid-boronophenylalanine-derived multifunctional vesicles for cancer chemoradiotherapy

Liqun Dai, J.F. Liu, Tingyu Yang et al. · Nature Communications · 2025 · 18 citations · Full text

LBA35 Phase II study of PARP inhibitor talazoparib and PD-L1 inhibitor avelumab in patients (pts) with microsatellite stable (MSS) recurrent/persistent endometrial cancer

P.A. Konstantinopoulos, A.A. Gockley, Niya Xiong et al. · Annals of Oncology · 2020 · 11 citations · Full text

, , +6

Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation

Yajuan Gao, Nanyang Zhou, J.F. Liu · Cancer Control · 2024 · 11 citations · Full text

1–4 of 4